Literature DB >> 7989719

Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection.

R P Gonzalez-Peralta1, G L Davis, J Y Lau.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7989719     DOI： 10.1016/s0168-8278(05)80405-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  11 in total

1.  Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism.

Authors:  Natalia Paladino; Hugo Fainboim; Graciela Theiler; Teresa Schroder; Alberto Eduardo Muñoz; Ana Claudia Flores; Omar Galdame; Leonardo Fainboim
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 2.  [Therapy of hepatitis C].

Authors:  D M Alscher; J C Bode
Journal:  Med Klin (Munich)       Date:  1997-03-15

3.  Longitudinal evaluation of the structure of replicating and circulating hepatitis C virus quasispecies in nonprogressive chronic hepatitis C patients.

Authors:  B Cabot; M Martell; J I Esteban; M Piron; T Otero; R Esteban; J Guardia; J Gómez
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection.

Authors:  B Kallinowski; K Haseroth; G Marinos; C Hanck; W Stremmel; L Theilmann; M V Singer; S Rossol
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

5.  Lymphocyte and macrophage phenotypes in chronic hepatitis C infection. Correlation with disease activity.

Authors:  S I Khakoo; P N Soni; K Savage; D Brown; A P Dhillon; L W Poulter; G M Dusheiko
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

6.  Viral replication in patients with concomitant hepatitis B and C virus infections.

Authors:  J Crespo; J L Lozano; B Carte; B de las Heras; F de la Cruz; F Pons-Romero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-06       Impact factor: 3.267

7.  Combination thymosin alpha 1 and lymphoblastoid interferon treatment in chronic hepatitis C.

Authors:  G Rasi; D DiVirgilio; M G Mutchnick; F Colella; P Sinibaldi-Vallebona; P Pierimarchi; B Valli; E Garaci
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

8.  Plasma hydroxy metronidazole/metronidazole ratio in anti-HCV carriers with and without apparent liver disease.

Authors:  C M da Silva; F L David; M N Muscará; S S Sousa; J G Ferraz; G de Nucci; N C Polimeno; J Pedrazzoli
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

9.  Significance of human leukocyte antigens DR3 and DR4 in chronic viral hepatitis.

Authors:  A J Czaja; H A Carpenter; P J Santrach; S B Moore
Journal:  Dig Dis Sci       Date:  1995-10       Impact factor: 3.199

10.  Identification of a functional, CRM-1-dependent nuclear export signal in hepatitis C virus core protein.

Authors:  Andrea Cerutti; Patrick Maillard; Rosalba Minisini; Pierre-Olivier Vidalain; Farzin Roohvand; Eve-Isabelle Pecheur; Mario Pirisi; Agata Budkowska
Journal:  PLoS One       Date:  2011-10-24       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.